Florida Medicaid Formulary Exclusions Are Not Final, Bristol Tells Investors
Executive Summary
The exclusion of Pravachol and Plavix from Florida's initial Medicaid formulary should not be considered final, Bristol-Myers Squibb Worldwide Group Medicines President Richard Lane told an investor conference call July 25.
You may also be interested in...
Medicare Rx Benefit Could Help Ignite COX-2 Market – Pharmacia’s Hassan
A Medicare drug benefit could help jump-start the stalled COX-2 inhibitor market, Pharmacia CEO Fred Hassan told analysts during the company's annual investor day in New York City Nov. 28
Medicare Rx Benefit Could Help Ignite COX-2 Market – Pharmacia’s Hassan
A Medicare drug benefit could help jump-start the stalled COX-2 inhibitor market, Pharmacia CEO Fred Hassan told analysts during the company's annual investor day in New York City Nov. 28
Rx Discounts Are “Price Industry Must Pay” For Medicare Benefit – Novartis
Discounts for the elderly will be the "price industry has to pay" for a Medicare prescription drug benefit, Novartis CEO Daniel Vasella predicted during a New York City analysts meeting Oct. 30